Camidanlumab
Camidanlumab (HuMax-TAC) is a humanized IgG1 monoclonal antibody against CD25. Camidanlumab can be used to synthesize the ADC molecule Camidanlumab tesirine. Camidanlumab can be used in the research of tumors such as lymphoma and leukemia. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
Product Specifications
CAS Number
921618-45-3
Product Name Alternative
HuMax-TAC
UNSPSC
12352203
Target
ADC Antibody; Interleukin Related; Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Antibody-drug Conjugate/ADC Related; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/camidanlumab.html
Purity
99.23
Solubility
10 mM in DMSO
Smiles
[Camidanlumab]
Molecular Weight
(143.98 kDa)
References & Citations
[1]Michael J Flynn, et al. ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies. Mol Cancer Ther. 2016 Nov;15 (11) :2709-2721.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC042368-100 1x 100 µL
Cytokeratin 6A (KRT6A) (Basal Cell Marker) (KRT6A/2368), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 